AMY XIONG: Open Payments
NPI 1366806473 · ELK GROVE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$155 in 7 payments from 7 companies in 2025. Trend: 2023 $201 · 2024 $222 · 2025 $155
Food & beverage: $155
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 1 | $32 |
| AstraZeneca Pharmaceuticals LP | 1 | $24 |
| Novocure Inc. | 1 | $23 |
| Incyte Corporation | 1 | $23 |
| Medline Industries LP | 1 | $19 |
| Rigel Pharmaceuticals, Inc. | 1 | $18 |
| Eisai Inc. | 1 | $17 |
Products named: SCEMBLIX, Optune Lua (NovoTTF-200T), MONJUVI, TAVALISSE, Lenvima.
Industry payments across CA — which companies pay providers there.
